A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritus
- 1 June 2017
- journal article
- research article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 86 (3) , 212-221
Abstract
No abstract availableKeywords
Funding Information
- Foundation of Strategic Research Projects in Private Universities
- Ministry of Education, Culture, Sports, Science, and Technology, Japan (15H04879, 15K15324, 16H05345, 26830114)
- Ministry of Health, Labour, and Welfare, Japan (150401-01)
This publication has 52 references indexed in Scilit:
- Neural processing of itchNeuroscience, 2013
- Responses to Intradermal Injections of Substance P in Psoriasis Patients with PruritusSkin Pharmacology and Physiology, 2009
- Skin immune sentinels in health and diseaseNature Reviews Immunology, 2009
- CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changesBritish Journal of Dermatology, 2008
- Humanized Anti-CD26 Monoclonal Antibody as a Treatment for Malignant Mesothelioma TumorsClinical Cancer Research, 2007
- Inhibitors of Dipeptidyl Peptidase IV and Aminopeptidase N Target Major Pathogenetic Steps in Acne InitiationJournal of Investigative Dermatology, 2007
- PsoriasisNew England Journal of Medicine, 2005
- Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities?Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2001
- Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseasesBritish Journal of Dermatology, 1996
- Liver dipeptidyl aminopeptidase IV hydrolyzes substance PFEBS Letters, 1978